Sinofert Holdings Ltd SNFRY

MaterialsChemicalsHong Kong

Last close 7.25 USD on Nov 2, 2026, −14.0% year to date

Quant rating

Quant rating D Rank 162 of 220 in Materials

Growth D 189 of 220
Valuation B 43 of 220
Quality D 183 of 220
Revisions C 150 of 220
Momentum C 135 of 220

Wall Street consensus Buy (2.00)Average target 0.20 USD −97.2%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 1.1B
Enterprise value: 787M
52-week range: 7.25 – 8.35
3-year range: 5.59 – 9.92
Dividend yield: 6.08%
Beta (5 years): –
Shares outstanding: 7,024M
Next earnings: Mar 25, 2027

About the company

Sinofert Holdings Ltd is an investment holding company principally engaged in the crop nutrition products business. The Company operates its business through three segments. The Basic Business segment engages in the procurement and sales of potash fertilizers, phosphate fertilizers and sulfur. The Growth Business segment is engaged in the research, production and sales of bio-compound fertilizers and specialty fertilizers as well as the sales of plant protection products and seeds. The Production segment is engaged in the production and sales of crop nutrition products. Additionally, the Company provides technology research and development and services for crop nutrition-related businesses and products, engages in the mining and exploration of phosphate rock and produces feed calcium. The products include potash fertilizers, nitrogen fertilizers, compound fertilizers and phosphate fertilizers, among others.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	3,327	2,913	3,061	3,335	3,564	–
Revenue growth	14.2%	−4.8%	−8.2%	−6.4%	8.8%	0.3%
EPS (basic, normalized)	–	–	–	0.02	0.02	–
EPS growth	–	–	–	19.7%	–	–
Gross margin	12.4%	12.0%	10.4%	11.2%	8.7%	10.9%
Net margin	5.4%	5.0%	2.9%	4.9%	3.8%	4.4%
ROE	11.6%	10.5%	6.5%	12.2%	10.3%	10.3%

Balance sheet, last quarter
Cash & short-term investments (mil)	–
Current ratio	–
Long-term debt (mil)	–
Net debt (mil)	–
Total equity (mil)	–
Net debt / equity	–
Net debt / EBITDA	–

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	3,327	+14.2%	0.2x	–	–	–	–	–	–
2026	3,843	+15.5%	0.2x	281	–	2.8x	0.03	–	262.7x
2027	4,012	+4.4%	0.2x	294	+4.5%	2.7x	0.03	+8.1%	243.0x
2028	4,236	+5.6%	0.2x	–	–	–	0.03	+14.8%	211.8x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	3,843	0.0%	–	–	0.03	0.0%	–	–
2027	4,012	0.0%	–	–	0.03	0.0%	–	–
2028	4,236	0.0%	–	–	0.03	0.0%	–	–

Earnings surprises

Reported results versus consensus, last 10 fiscal quarters
	FQ-9	FQ-8	FQ-7	FQ-6	FQ-5	FQ-4	FQ-3	FQ-2	FQ-1	FQ0
Sales reported (mil)	–	–	–	–	–	–	–	–	–	–
Sales mean (mil)	–	–	–	–	–	–	–	–	–	–
Surprise	–	–	–	–	–	–	–	–	–	–
EPS reported	–	–	–	–	–	–	–	–	–	–
EPS mean	–	–	–	–	–	–	–	–	–	–
Surprise	–	–	–	–	–	–	–	–	–	–

FQ0 is the most recent reported quarter, FQ-1 the one before, and so on.

Peer comparison Chemicals

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
SNFRY Sinofert Holdings Ltd	1.1B	–	5.4%	0.59x	262.7x	243.0x	2.8x	2.7x
LNXSY Lanxess AG	1.1B	3.69x	−10.2%	0.30x	−4.5x	−11.5x	6.0x	5.4x
ECVT Ecovyst Inc.	1.1B	2.36x	0.9%	1.87x	14.5x	11.6x	7.4x	6.5x
VTXPY Victrex PLC	1.1B	–	9.4%	2.20x	8.7x	7.3x	11.5x	10.5x
CBLUY China BlueChemical Ltd	1.1B	–	8.1%	0.38x	277.9x	263.0x	−1.9x	−1.9x
FMC FMC Corp	1.0B	4.12x	−63.5%	−52.12x	−3.9x	5.2x	16.8x	7.1x
Mean		3.39x	−8.3%	−7.80x	92.6x	86.4x	7.1x	5.0x
Median		3.69x	3.1%	0.48x	11.6x	9.4x	6.7x	6.0x

Technical analysis

1M−13.2%
3M−14.0%
1Y−14.0%
3Y+29.7%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, Sinofert Holdings Ltd, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	3,327	2,913	3,061	3,335	3,564	3,277
Cost of revenue	2,913	2,565	2,743	2,962	3,256	2,972
Gross profit	414	349	318	374	309	305
Selling, general & administrative expenses	201	211	172	187	204	220
Research & development	–	–	–	–	–	–
Interest expense (income), operating	−20.7	−9.6	−12.3	−8.4	−13.6	−9.6
Unusual expense (income)	27.3	−6.2	6.3	0.5	9.4	3.8
Other operating expenses	−7.8	8.6	41.2	40.3	−4.3	−6.6
Operating income	214	145	111	154	113	96.4
Net interest income (expense)	7.3	22.8	7.8	18.2	28.4	6.6
Gain (loss) on sale of assets	–	–	–	–	–	–
Other non-operating income (expense)	0	0	0	0	0	0
Net income before taxes	221	168	119	172	142	103
Provision for taxes	39.4	20.4	22.8	9.0	3.1	2.8
Minority interest	−2.0	−1.9	−8.3	−1.1	−2.2	−1.4
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	180	145	88.1	162	136	98.7
Extraordinary items	–	–	–	–	–	–
Net income	180	145	88.1	162	136	98.7
EBIT, normalized	221	129	105	146	109	90.6
EBITDA, normalized	292	194	166	190	150	132
Basic EPS, normalized	–	–	–	0.02	0.02	–

Balance sheet in millions of USD, fiscal years

Balance sheet, Sinofert Holdings Ltd, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	604	522	552	487	207	118
Receivables	140	134	230	170	297	254
Total inventory	834	716	801	822	756	816
Prepaid expenses	285	194	235	235	221	234
Other current assets	138	131	172	132	125	0
Total current assets	2,001	1,698	1,991	1,846	1,606	1,422
Property, plant & equipment	740	722	756	757	698	634
Goodwill	122	118	120	123	129	127
Intangibles	37.9	41.1	42.7	48.2	56.9	76.1
Long-term investments	464	343	179	230	251	203
Note receivable	–	0	–	–	0	146
Other long-term assets	8.3	11.9	7.8	14.6	12.7	13.7
Total assets	3,373	2,934	3,097	3,019	2,754	2,622
Liabilities
Accounts payable	632	450	531	362	380	372
Payable/accrued	–	–	–	–	–	–
Accrued expenses	107	92.9	96.8	115	106	25.4
Short-term debt	0	0	0	0	0	263
Current portion of long-term debt	121	123	86.3	68.1	13.4	6.2
Other current liabilities	756	650	783	835	627	642
Total current liabilities	1,616	1,317	1,498	1,381	1,127	1,308
Long-term debt	94.1	133	171	195	159	1.9
Minority interest	33.0	29.8	29.2	33.1	37.9	25.0
Other liabilities	24.8	27.1	30.4	31.6	54.1	60.3
Total liabilities	1,768	1,507	1,729	1,641	1,378	1,396
Shareholders' equity
Preferred stock	–	–	–	–	–	–
Common stock	842	807	829	854	927	902
Additional paid-in capital	–	–	–	–	–	–
Retained earnings (accumulated deficit)	876	739	655	641	562	413
Treasury stock	–	–	–	–	–	–
Other equity	−113	−118	−116	−117	−112	−88.2
Total equity	1,605	1,427	1,368	1,378	1,376	1,227
Total liabilities & shareholders' equity	3,373	2,934	3,097	3,019	2,754	2,622

Cash flow statement in millions of USD, fiscal years

Cash flow statement, Sinofert Holdings Ltd, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	221	168	119	172	142	103
Depreciation, depletion & amortization	71.6	64.7	61.0	44.3	41.0	41.8
Deferred taxes	–	–	–	–	–	–
Non-cash items	−23.1	−10.1	23.7	17.7	18.9	−8.6
Changes in working capital	15.1	−79.4	146	56.5	45.3	15.6
Cash from operations	285	143	350	290	247	152
Investing activities
Capital expenditures	−44.5	−37.8	−76.6	−179	−220	−112
Other investing cash flows	−130	−168	−129	157	203	8.5
Cash from investing	−175	−206	−205	−22.2	−16.4	−104
Financing activities
Financing cash flow items	−6.4	−6.8	−9.8	−21.1	−1.4	9.1
Cash dividends paid	−75.1	−43.1	−57.3	−46.7	−30.6	−29.8
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	−51.5	1.1	−0.2	94.6	−111	−114
Cash from financing	−133	−48.8	−67.3	26.8	−143	−135
Foreign exchange effects	−2.1	1.9	0.3	1.0	−0.3	−0.9
Net change in cash	−25.1	−110	77.6	296	86.8	−87.6
Free cash flow	241	105	274	112	27.3	39.5

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 2, 2026 after market close.